Opus Genetics IRD Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount at other companies
Other financials
Where this comes from
Reported directly by Opus Genetics in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance.
The official record: Opus Genetics’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Opus Genetics's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Opus Genetics's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount?
- Opus Genetics (IRD) reported effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount of $1.15M in Q4 2025.
- What does effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount mean?
- The adjustment to the valuation allowance for deferred tax assets, reflecting changes in the company's assessment of whether it is more likely than not that these assets will be realized. A significant change often indicates management's evolving outlook on future profitability and the ability to utilize tax carryforwards.